Actively Recruiting

All Genders
Healthy Volunteers
ID04586400

Genotype-Phenotype Correlation in Patients With Chromosome 9P Minus Syndrome

Led by Washington University School of Medicine · Updated on 2024-08-05

200

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

W

Washington University School of Medicine

Lead Sponsor

D

Dickson, Patricia I., M.D.

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research focuses on patients with a rare condition called Chromosome 9P Deletion Syndrome, where a part of chromosome 9 is missing. Because only about 200 cases have been reported in medical literature, the study aims to better understand the link between the specific deleted genes and the diverse physical traits seen in affected individuals. Researchers will use advanced genome sequencing techniques to analyze the size and location of the chromosome deletion and examine the genetic background of each patient. Participants will undergo whole genome sequencing to gather detailed genetic information. Alongside this, they will complete a thorough questionnaire and provide a biospecimen sample for analysis. Family members, such as parents and siblings, may also participate to help clarify how genetic background influences physical characteristics related to the condition. During the study, participants will provide medical information through questionnaires and biospecimens, which researchers will use to identify correlations between genetic changes and physical traits. The main outcome measured is the relationship between genotype and phenotype, with preliminary results expected as enrollment increases. The study is observational, and participants' involvement will mainly consist of providing samples and information for research purposes.

CONDITIONS

Brief Title

Chromosome 9 P Minus Syndrome

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of 9P minus syndrome or deletions on the 9th chromosome
  • Parents and siblings of affected individuals may participate to study genetic background contributions
Not Eligible

You will not qualify if you...

  • There are no exclusion criteria for affected individuals or their family members

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 5 years

Participants undergo assessments to study genetic and phenotypic characteristics related to Chromosome 9P Minus Syndrome.

Visits as needed depending on study assessments

Trial Site Locations

Total: 1 location

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

F

F. S. Cole, M.D.

S

Sophia Couteranis

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here